Monday, June 15, 2026

SK Hynix Targets 15 Trillion KRW with U.S. ADR Listing: What It Means for AI Semiconductor Dominance

SK Hynix plans to list ADRs in the U.S. to raise up to 15 trillion KRW, aiming to enhance its HBM production and market valuation.

Unveiling 30 Years Later: South Korea and Israel’s Secret Defense Talks on North Korean Arms

Declassified documents reveal South Korea and Israel's 1990s efforts to form a joint task force addressing North Korea's arms exports.

Hyundai’s Safety-First Focus Drives Big Growth Worldwide

Hyundai Motor Group's global sales surge is driven by top safety ratings and commitment to R&D, ensuring high-value, safe vehicles.

Tag: SK Bioscience

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

SK Bioscience Opens Songdo Headquarters to Families as It Expands Employee-Centered Corporate Culture

SK Bioscience hosted a family open house at its new headquarters, showcasing its vision and engaging activities for employees' families.

SK Bioscience Builds Latin American Growth Momentum With Local Vaccine Manufacturing Collaboration in Colombia

SK bioscience accelerates its expansion into the Latin American market with its self-developed vaccine.

SK Bioscience Pours 4 Billion KRW into RSM01, Accelerating RSV Antibody Trials

SK Bioscience secures funding from the Light Foundation to support clinical trials for its RSV prevention monoclonal antibody RSM01.

Why Ebola Now? SK Bioscience Joins a $30 Million Global Push to Rethink Ebola Vaccine Production

SK Bioscience secures funding to enhance Ebola vaccine production, improving yield and stability for better accessibility amid outbreaks.

How SK Bioscience Plans to Dominate the Global Vaccine Market in 2026

SK Bioscience enhances its operational system with new COO and key appointments to boost global competitiveness and vaccine development.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.